HAUS3 (HAUS augmin-like complex subunit 3) is a component of the HAUS complex, which is essential for mitotic spindle assembly, centrosome integrity, and cytokinesis . It ensures proper microtubule organization during cell division, making it critical for maintaining genomic stability . Dysregulation of HAUS3 is linked to tumor progression, particularly in HCC, where its overexpression correlates with poor clinical outcomes .
HAUS3 regulates G2/M phase transition by modulating:
Western Blot: Detects HAUS3 at ~25 kDa in human cell lysates (e.g., HeLa cells) .
Immunohistochemistry (IHC): Used to quantify HAUS3 expression in clinical HCC samples, linking it to tumor grade and survival .
Functional Studies: Employed in siRNA/shRNA knockdown experiments to explore HAUS3’s role in cell cycle arrest and tumor growth inhibition .
Knockdown: Reduces HCC cell proliferation and induces G2/M arrest (p < 0.001) .
Overexpression: Accelerates G2/M transition and promotes tumor growth in xenograft models .
| Target | Regulation by HAUS3 | Functional Outcome |
|---|---|---|
| PLK1-T210 phosphorylation | Increased | Mitotic progression |
| Cdk1-Y15 phosphorylation | Decreased | Activation of Cdk1/cyclin B1 complex |
| Cyclin B1 levels | Upregulated | G2/M phase transition |
HAUS3 Antibody contributes to mitotic spindle assembly, maintenance of centrosome integrity, and completion of cytokinesis as part of the HAUS augmin-like complex.
HAUS3, also known as C4orf15, is a component of the HAUS augmin-like complex which regulates mitotic spindle assembly and centrosome integrity and is required for completion of cytokinesis. The complex interacts with the gamma-tubulin ring complex, and this interaction is essential for proper spindle assembly during cell division . HAUS3 contributes to maintaining centrosome integrity and proper mitotic progression, making it an important target for cell division studies .
While the calculated molecular weight of HAUS3 is approximately 70 kDa, it is typically observed at 62-65 kDa in experimental conditions such as Western blot analysis . This discrepancy between calculated and observed molecular weights is important to consider when designing experiments and interpreting results. The difference may be attributed to post-translational modifications, protein folding characteristics, or alternative splicing that affect gel migration patterns.
HAUS3 demonstrates specific subcellular localization patterns associated with its function in mitosis. The protein localizes to interphase centrosomes and to mitotic spindle microtubules during cell division . This distinct localization pattern is consistent with its role in spindle assembly and centrosome function, making it an excellent marker for studying centrosome dynamics and mitotic progression in various research contexts.
Several types of HAUS3 antibodies are available for research applications, including:
Polyclonal antibodies targeting different epitopes (e.g., AA 1-100, AA 138-187, AA 291-340, AA 372-400, AA 379-408, AA 384-603)
Conjugated antibodies (AbBy Fluor® 594, Biotin) for specialized detection methods
When selecting an antibody, researchers should consider:
The specific epitope required for their application
The species reactivity needed (human, mouse, rat)
The intended application (WB, IHC, IF, ELISA, FACS)
Whether a conjugated or unconjugated antibody is more suitable for the detection system
Validating HAUS3 antibody specificity requires multiple approaches:
Testing in positive control cell lines with known HAUS3 expression (HepG2 and HeLa cells have been confirmed to express HAUS3)
Performing knockdown/knockout experiments as negative controls
Confirming the correct molecular weight band (62-65 kDa) in Western blots
Verifying expected subcellular localization pattern (centrosomes and spindle microtubules) using immunofluorescence
Cross-validating results using multiple antibodies targeting different epitopes of HAUS3
Most commercial HAUS3 antibodies demonstrate reactivity with human samples, with some showing cross-reactivity with mouse and rat models . When working with non-human species, it's essential to:
Verify sequence homology between human HAUS3 and the target species
Perform preliminary validation experiments with appropriate controls
Consider that antibodies targeting different epitopes may show different cross-reactivity profiles
Note that an antibody showing reactivity with human, guinea pig, and bat samples has been reported for specific epitopes (AA 138-187)
For successful Western blot detection of HAUS3:
For optimal results, researchers should:
Include protease inhibitors in lysis buffers to prevent degradation
Optimize transfer conditions for the relatively large protein
Consider longer blocking and antibody incubation times for enhanced specificity
For immunofluorescence applications:
Fix cells using 4% paraformaldehyde (10-15 minutes at room temperature)
Permeabilize with 0.2% Triton X-100 in PBS (10 minutes)
Block with 5% BSA or normal serum (1 hour)
Use appropriate fluorophore-conjugated secondary antibody or direct-conjugated primary (like AbBy Fluor® 594)
Co-stain with centrosome/microtubule markers and DNA dyes for proper localization analysis
Analyze using confocal or super-resolution microscopy
For enhanced visualization of centrosomal structures, consider:
Co-staining with γ-tubulin as a centrosome marker
Using cell cycle synchronization to enrich for mitotic cells
Implementing z-stack imaging to capture the full three-dimensional structure
For immunohistochemistry applications:
For optimal IHC results:
Test both suggested antigen retrieval methods to determine optimal conditions
Include appropriate positive and negative controls in each experimental run
Consider slide-to-slide variability when interpreting results
Optimize antibody incubation time and temperature based on signal strength
HAUS3 antibodies offer valuable tools for investigating spindle assembly mechanisms:
Use immunofluorescence to track HAUS3 localization throughout mitotic progression
Perform co-immunoprecipitation experiments to identify HAUS3 interaction partners during spindle assembly
Combine with tubulin staining to analyze microtubule organization and density in normal versus compromised conditions
Implement live-cell imaging with fluorescently tagged HAUS3 to monitor dynamic recruitment to spindle structures
Compare HAUS3 localization patterns in cells treated with microtubule-stabilizing or destabilizing agents
In these experiments, researchers should focus on the role of HAUS3 in mediating interactions between centrosomes and spindle microtubules, particularly through its association with the gamma-tubulin ring complex.
To investigate HAUS3's contribution to centrosome integrity:
Use super-resolution microscopy with HAUS3 antibodies to examine detailed centrosome structure
Perform HAUS3 knockdown/knockout studies and analyze resulting centrosome abnormalities
Examine HAUS3 recruitment during centrosome duplication using synchronized cell populations
Investigate potential phosphorylation or other post-translational modifications of HAUS3 during centrosome cycle
Study HAUS3 localization and function in cells with centrosome amplification
These approaches can provide insights into how HAUS3 contributes to maintaining proper centrosome structure and function throughout the cell cycle.
To study the critical interaction between HAUS3 and the gamma-tubulin ring complex:
Perform co-immunoprecipitation using HAUS3 antibodies followed by immunoblotting for gamma-tubulin components
Conduct proximity ligation assays to visualize in situ protein-protein interactions
Use fluorescence resonance energy transfer (FRET) to detect direct molecular interactions
Implement structured illumination microscopy to visualize co-localization at the nanoscale level
Compare interaction dynamics during different cell cycle phases and under various perturbation conditions
Understanding this interaction is crucial as it represents a key mechanism by which HAUS3 contributes to proper spindle assembly during mitosis.
When encountering unexpected results:
For multiple Western blot bands:
Consider potential alternative splicing or isoforms of HAUS3
Evaluate whether bands represent post-translationally modified forms
Test for potential degradation products by modifying sample preparation
Validate specific bands using siRNA knockdown
Compare results across multiple antibodies targeting different epitopes
For atypical immunofluorescence patterns:
Verify fixation and permeabilization conditions are appropriate
Compare with literature-reported localization patterns
Use co-staining with established centrosome/spindle markers
Test different cell types to rule out cell-specific variations
Optimize antibody concentration to reduce non-specific binding
Proper experimental design requires appropriate controls:
Positive controls: HepG2 or HeLa cells for Western blot and immunofluorescence applications
Negative controls: Primary antibody omission, isotype controls, and HAUS3-depleted samples
Specificity controls: Competing peptide blocking or pre-absorption tests
Cross-reactivity controls: Testing in species with predicted reactivity (mouse, rat)
Application-specific controls: Loading controls for Western blot, tissue-specific positive controls for IHC, and co-staining controls for IF
For challenging detection scenarios:
Test different epitope-targeting antibodies if one region proves difficult to detect
Consider alternative sample preparation methods for better antigen preservation
Implement signal amplification systems for low-abundance detection
Test both N-terminal and C-terminal targeting antibodies to ensure complete detection
Optimize blocking conditions to reduce background in high-sensitivity applications
Consider specialized fixation protocols for preserving delicate centrosome structures
HAUS3 antibodies offer valuable tools for cancer research:
Compare HAUS3 expression between normal and malignant tissues using IHC and Western blot
Correlate expression with markers of chromosomal instability and centrosome amplification
Examine HAUS3 localization in cancer cells with abnormal mitotic spindles
Investigate potential correlations between HAUS3 expression/localization and cancer progression
Study the effects of anti-mitotic drugs on HAUS3 function in cancer cells
Analyze HAUS3 expression in human liver cancer tissue, which has been validated as a positive control
For developmental and stem cell applications:
Select antibodies validated in appropriate developmental model systems
Compare HAUS3 expression and localization between stem cells and differentiated cells
Analyze HAUS3 function during symmetric versus asymmetric cell divisions
Investigate potential roles in centrosome inheritance during development
Consider epitope accessibility, which may vary in different developmental contexts
Optimize fixation conditions carefully, as embryonic tissues often require specialized protocols
For neurodegenerative disease research:
Examine HAUS3 expression in neural cells with centrosome-related defects
Investigate potential alterations in mitotic spindle assembly in disease models
Study HAUS3 interactions with disease-associated proteins
Analyze centrosome structure in patient-derived samples
Explore connections between centrosome abnormalities and neurodevelopmental disorders
Consider both dividing neural progenitors and post-mitotic neurons in experimental design
For maintaining antibody quality:
Avoid repeated freeze-thaw cycles by preparing small aliquots
Store diluted working solutions at 4°C for short-term use only
Some formulations contain 50% glycerol, which prevents freezing at -20°C
Typical shelf life is 12 months from receipt when properly stored
Antibody formulations typically include:
Some formulations may include BSA as a carrier protein
The typical concentration is 0.05-2 mg/ml depending on the supplier
Understanding these formulation details is important when planning downstream applications, particularly those sensitive to buffer components or requiring specific antibody concentrations.
When documenting unexpected findings:
Maintain detailed records of all experimental conditions
Document antibody lot numbers, as performance can vary between lots
Compare results with published literature and known HAUS3 biology
Consider reaching out to antibody manufacturers for technical support
Design follow-up experiments to systematically investigate anomalous results
Share experiences with unexpected binding patterns or molecular weights with the research community